Role of GDNF Family Ligands in Photoreceptor Rescue

GDNF 家族配体在光感受器救援中的作用

基本信息

  • 批准号:
    6858852
  • 负责人:
  • 金额:
    $ 15.62万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2005
  • 资助国家:
    美国
  • 起止时间:
    2005-02-01 至 2010-01-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The candidate's long-term aims are to develop a better molecular understanding of photoreceptor cell death in retinal degenerative diseases, and to use this information to develop novel treatments for these conditions. Photoreceptor cell death is the final, irreversible step in the progression of blinding diseases such as retinitis pigmentosa and age-related macular degeneration. Limited treatment options are available for individuals with these conditions. One therapeutic strategy seeks to provide neurotrophic factors to the diseased retina in an effort to prolong photoreceptor cell survival. The GDNF family ligands (GFLs) in conjunction with their respective GDNF family receptors (GFRas) activate intracellular signaling through the Ret tyrosine kinase. These factors are potent survival factors for dopaminergic, sympathetic, and parasympathetic neurons. Members of the GDNF family have been localized to the retina, and may play important roles in retinal development and maintenance. The laboratory of the candidate's sponsor has been instrumental in defining the physiologic roles of many of the GDNF family members. The laboratory has all the available resources, including mouse models, antibodies, probes, and the expertise currently in place to facilitate successful completion of this research proposal. With the guidance of his sponsor, the candidate proposes to investigate the function of the GFLs in normal retinal development and to assess their ability to slow photoreceptor cell death in models of retinal degeneration. He will (1) determine the spatial and temporal expression patterns of GDNF family members in the normal murine retina, (2) determine the retinal phenotype produced by loss-of-function mutations in the GFLs, GFRas, and Ret, and (3) to investigate whether gain-of-function mutations in GFLs can slow photoreceptor cell death in mice with retinal degeneration.
描述(申请人提供):候选人的长期目标是对视网膜退行性疾病中的光感受器细胞死亡有更好的分子理解,并利用这些信息开发针对这些疾病的新疗法。光感受器细胞死亡是视网膜色素变性和老年性黄斑变性等致盲疾病进展过程中不可逆转的最后一步。对于患有这些疾病的个人,治疗选择有限。一种治疗策略寻求为患病的视网膜提供神经营养因子,以努力延长光感受器细胞的存活时间。GDNF家族配体(GFL)与其各自的GDNF家族受体(GFRA)通过Ret酪氨酸激酶激活细胞内信号。这些因素是多巴胺能神经元、交感神经元和副交感神经元的有效生存因素。GDNF家族的成员已经定位于视网膜,并可能在视网膜的发育和维持中发挥重要作用。候选人赞助商的实验室在确定许多GDNF家族成员的生理角色方面起到了重要作用。实验室拥有所有可用的资源,包括小鼠模型、抗体、探针和目前到位的专业知识,以促进这项研究提案的成功完成。在赞助商的指导下,候选人提议研究GFL在正常视网膜发育中的功能,并评估它们在视网膜变性模型中减缓光感受器细胞死亡的能力。他将(1)确定GDNF家族成员在正常小鼠视网膜中的空间和时间表达模式;(2)确定GFLS、GFRas和Ret功能缺失突变所产生的视网膜表型;(3)研究GFLS功能获得突变是否可以减缓视网膜变性小鼠的光感受器细胞死亡。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Milam A Brantley其他文献

Milam A Brantley的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Milam A Brantley', 18)}}的其他基金

Proteomics of human vitreous to investigate mechanisms underlying the variability in anti-VEGF treatment response in neovascular AMD patients
人玻璃体蛋白质组学研究新生血管性 AMD 患者抗 VEGF 治疗反应差异的机制
  • 批准号:
    10507176
  • 财政年份:
    2022
  • 资助金额:
    $ 15.62万
  • 项目类别:
Proteomics of human vitreous to investigate mechanisms underlying the variability in anti-VEGF treatment response in neovascular AMD patients
人玻璃体蛋白质组学研究新生血管性 AMD 患者抗 VEGF 治疗反应差异的机制
  • 批准号:
    10673722
  • 财政年份:
    2022
  • 资助金额:
    $ 15.62万
  • 项目类别:
Metabolomic and Genetic Interactions in Age-Related Macular Degeneration
年龄相关性黄斑变性的代谢组学和遗传相互作用
  • 批准号:
    8576080
  • 财政年份:
    2013
  • 资助金额:
    $ 15.62万
  • 项目类别:
Metabolomic and Genetic Interactions in Age-Related Macular Degeneration
年龄相关性黄斑变性的代谢组学和遗传相互作用
  • 批准号:
    8717668
  • 财政年份:
    2013
  • 资助金额:
    $ 15.62万
  • 项目类别:
Metabolomic and Genetic Interactions in Age-Related Macular Degeneration
年龄相关性黄斑变性的代谢组学和遗传相互作用
  • 批准号:
    9302786
  • 财政年份:
    2013
  • 资助金额:
    $ 15.62万
  • 项目类别:
Training Program in Quantitative Ocular Genomics
定量眼部基因组学培训计划
  • 批准号:
    8661188
  • 财政年份:
    2011
  • 资助金额:
    $ 15.62万
  • 项目类别:
Training Program in Quantitative Ocular Genomics
定量眼部基因组学培训计划
  • 批准号:
    8463545
  • 财政年份:
    2011
  • 资助金额:
    $ 15.62万
  • 项目类别:
Training Program in Quantitative Ocular Genomics
定量眼部基因组学培训计划
  • 批准号:
    9317489
  • 财政年份:
    2011
  • 资助金额:
    $ 15.62万
  • 项目类别:
Training Program in Quantitative Ocular Genomics
定量眼部基因组学培训计划
  • 批准号:
    8800555
  • 财政年份:
    2011
  • 资助金额:
    $ 15.62万
  • 项目类别:
Role of GDNF Family Ligands in Photoreceptor Rescue
GDNF 家族配体在光感受器救援中的作用
  • 批准号:
    7364163
  • 财政年份:
    2005
  • 资助金额:
    $ 15.62万
  • 项目类别:

相似海外基金

CAREER: Elucidating spatial and epigenetic regulation of gene expression during human development using photopatterning and single-cell multiomics
职业:利用光模式和单细胞多组学阐明人类发育过程中基因表达的空间和表观遗传调控
  • 批准号:
    2339849
  • 财政年份:
    2024
  • 资助金额:
    $ 15.62万
  • 项目类别:
    Continuing Grant
CAREER: Scalable algorithms for regularized and non-linear genetic models of gene expression
职业:基因表达的正则化和非线性遗传模型的可扩展算法
  • 批准号:
    2336469
  • 财政年份:
    2024
  • 资助金额:
    $ 15.62万
  • 项目类别:
    Continuing Grant
CAREER: Epigenetic Regulation of Gene Expression in Engineered Prokaryotes
职业:工程原核生物基因表达的表观遗传调控
  • 批准号:
    2338573
  • 财政年份:
    2024
  • 资助金额:
    $ 15.62万
  • 项目类别:
    Continuing Grant
MFB: RNA modifications of frameshifting stimulators: cellular platforms to engineer gene expression by computational mutation predictions and functional experiments
MFB:移码刺激器的RNA修饰:通过计算突变预测和功能实验来设计基因表达的细胞平台
  • 批准号:
    2330628
  • 财政年份:
    2024
  • 资助金额:
    $ 15.62万
  • 项目类别:
    Standard Grant
22-BBSRC/NSF-BIO Building synthetic regulatory units to understand the complexity of mammalian gene expression
22-BBSRC/NSF-BIO 构建合成调控单元以了解哺乳动物基因表达的复杂性
  • 批准号:
    BB/Y008898/1
  • 财政年份:
    2024
  • 资助金额:
    $ 15.62万
  • 项目类别:
    Research Grant
How does the chromatin remodeller CHD4 regulate gene expression?
染色质重塑因子 CHD4 如何调节基因表达?
  • 批准号:
    DP240102119
  • 财政年份:
    2024
  • 资助金额:
    $ 15.62万
  • 项目类别:
    Discovery Projects
Application for 2024 CIHR NIF (ECR): Investigating the role of SARS-CoV-2 and MERS-CoV transcription regulatory sequence (TRS) in viral gene expression and virulence
2024 CIHR NIF (ECR) 申请:研究 SARS-CoV-2 和 MERS-CoV 转录调控序列 (TRS) 在病毒基因表达和毒力中的作用
  • 批准号:
    491942
  • 财政年份:
    2023
  • 资助金额:
    $ 15.62万
  • 项目类别:
Regulation of gene expression by the La and La-related proteins
La 和 La 相关蛋白对基因表达的调节
  • 批准号:
    489704
  • 财政年份:
    2023
  • 资助金额:
    $ 15.62万
  • 项目类别:
    Operating Grants
Investigating the role of SARS-CoV-2 and MERS-CoV transcription regulatory sequence (TRS) in viral gene expression and virulence
研究 SARS-CoV-2 和 MERS-CoV 转录调控序列 (TRS) 在病毒基因表达和毒力中的作用
  • 批准号:
    494272
  • 财政年份:
    2023
  • 资助金额:
    $ 15.62万
  • 项目类别:
    Operating Grants
Data-driven model links BMIz to gene expression in pediatric asthma
数据驱动模型将 BMIz 与小儿哮喘基因表达联系起来
  • 批准号:
    493135
  • 财政年份:
    2023
  • 资助金额:
    $ 15.62万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了